These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8841400)

  • 1. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
    Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
    Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
    Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
    Newell JL; Fay PJ
    J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
    Donath MS; Lenting PJ; van Mourik JA; Mertens K
    J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
    Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
    Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
    Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
    Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of factor VIII and mechanisms of cofactor action.
    Fay PJ
    Blood Rev; 2004 Mar; 18(1):1-15. PubMed ID: 14684146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage at Arg-1689 influences heavy chain cleavages during thrombin-catalyzed activation of factor VIII.
    Newell JL; Fay PJ
    J Biol Chem; 2009 Apr; 284(17):11080-9. PubMed ID: 19240027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
    Hill-Eubanks DC; Lollar P
    J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA.
    Fay PJ; Mastri M; Koszelak ME; Wakabayashi H
    J Biol Chem; 2001 Apr; 276(15):12434-9. PubMed ID: 11278520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X.
    Neuenschwander P; Jesty J
    Blood; 1988 Nov; 72(5):1761-70. PubMed ID: 3140913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of porcine factor VIII:C by thrombin and factor Xa.
    Lollar P; Knutson GJ; Fass DN
    Biochemistry; 1985 Dec; 24(27):8056-64. PubMed ID: 3937553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
    Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
    Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human protein S cleavage and inactivation by coagulation factor Xa.
    Long GL; Lu D; Xie RL; Kalafatis M
    J Biol Chem; 1998 May; 273(19):11521-6. PubMed ID: 9565566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.
    Eaton D; Rodriguez H; Vehar GA
    Biochemistry; 1986 Jan; 25(2):505-12. PubMed ID: 3082357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a factor Xa-interactive site within residues 337-372 of the factor VIII heavy chain.
    Nogami K; Lapan KA; Zhou Q; Wakabayashi H; Fay PJ
    J Biol Chem; 2004 Apr; 279(16):15763-71. PubMed ID: 14764590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of factor VIII C2 domain in factor VIII binding to factor Xa.
    Nogami K; Shima M; Hosokawa K; Suzuki T; Koide T; Saenko EL; Scandella D; Shibata M; Kamisue S; Tanaka I; Yoshioka A
    J Biol Chem; 1999 Oct; 274(43):31000-7. PubMed ID: 10521497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit structure and function of porcine factor Xa-activated factor VIII.
    Parker ET; Pohl J; Blackburn MN; Lollar P
    Biochemistry; 1997 Aug; 36(31):9365-73. PubMed ID: 9235979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.